Amicus Therapeutics Inc - Company Profile

All the data and insights you need on Amicus Therapeutics Inc in one report.

$295

Buy Report View Sample

Save hours of research time and resources with
our up-to-date Amicus Therapeutics Inc Strategy Report
Understand Amicus Therapeutics Inc position in the market,
performance and strategic initiatives.
Gain competitive edge and increase your
chances of success

Amicus Therapeutics Inc: Patents

View up-to-date information on Amicus Therapeutics Inc patents, including inventor and filing insights.

Publication Identifier	Document Type	Title	Classification-CPC	Publication Date
EP3675853B1	Grant	VERFAHREN ZUR VERSTÄRKUNG UND/ODER STABILISIERUNG DER HERZFUNKTION IN PATIENTEN MIT MORBUS FABRY	A61K31/445; A61K9/08; A61K9/20; A61K9/48; A61P43/00; A61P9/00; A61P9/04	September 07, 2022
AR122298A1	Application	MÉTODOS PARA TRATAR LA ENFERMEDAD DE FABRY EN PACIENTES QUE TIENEN UNA MUTACIÓN EN EL GEN GLA		August 31, 2022
AR122260A1	Application	COMPOSICIONES ÚTILES PARA EL TRATAMIENTO DE LA ENFERMEDAD DE POMPE		August 31, 2022
SI3436053T1	Grant	FORMULATIONS COMPRISING RECOMBINANT ACID ALPHA-GLUCOSIDASE	A61K38/47; C12N9/2408; C12Y302/0102	August 31, 2022
ES2921673T3	Grant	Formulaciones que contienen alfa-glucosidasa ácida recombinante	A61K38/47; C12N9/2408; C12Y302/0102	August 30, 2022

Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Find out more

Name	Count

Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Find out more

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Contact the team or request a demo to find out how our data can drive your business forward